Michael A Calderwood, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Herpesvirus 2, Saimiriine | 9 | 2005 | 61 | 1.010 |
Why?
|
| Herpesvirus 4, Human | 3 | 2009 | 1082 | 0.450 |
Why?
|
| Genes, Viral | 3 | 2005 | 655 | 0.310 |
Why?
|
| Antigens, Viral | 4 | 2009 | 992 | 0.300 |
Why?
|
| Open Reading Frames | 4 | 2005 | 812 | 0.260 |
Why?
|
| Viral Proteins | 3 | 2008 | 1802 | 0.240 |
Why?
|
| Epstein-Barr Virus Infections | 2 | 2008 | 617 | 0.230 |
Why?
|
| Virus Latency | 3 | 2005 | 360 | 0.220 |
Why?
|
| Plasmids | 3 | 2008 | 2267 | 0.220 |
Why?
|
| Nuclear Proteins | 4 | 2005 | 5802 | 0.200 |
Why?
|
| Virus Replication | 2 | 2008 | 2458 | 0.180 |
Why?
|
| Chromosomes | 1 | 2004 | 579 | 0.180 |
Why?
|
| Gene Transfer Techniques | 1 | 2004 | 1209 | 0.160 |
Why?
|
| Mitosis | 1 | 2004 | 1190 | 0.150 |
Why?
|
| Genetic Vectors | 2 | 2004 | 3411 | 0.120 |
Why?
|
| Trans-Activators | 4 | 2008 | 2855 | 0.120 |
Why?
|
| Proteins | 1 | 2007 | 6006 | 0.100 |
Why?
|
| Genome, Viral | 3 | 2005 | 673 | 0.100 |
Why?
|
| Transfection | 3 | 2008 | 5758 | 0.080 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2009 | 133 | 0.080 |
Why?
|
| Gene Expression Regulation, Viral | 2 | 2000 | 435 | 0.070 |
Why?
|
| Gene Deletion | 2 | 2005 | 2673 | 0.070 |
Why?
|
| Luciferases | 1 | 2008 | 712 | 0.070 |
Why?
|
| Immediate-Early Proteins | 1 | 2008 | 444 | 0.060 |
Why?
|
| COS Cells | 2 | 2004 | 1135 | 0.060 |
Why?
|
| Genes, Reporter | 1 | 2008 | 1524 | 0.060 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2003 | 125 | 0.060 |
Why?
|
| Terminal Repeat Sequences | 1 | 2003 | 70 | 0.060 |
Why?
|
| Point Mutation | 2 | 2009 | 1595 | 0.050 |
Why?
|
| Dimerization | 1 | 2004 | 886 | 0.050 |
Why?
|
| Transgenes | 1 | 2004 | 1015 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2009 | 2846 | 0.040 |
Why?
|
| Cell Line | 3 | 2008 | 15593 | 0.040 |
Why?
|
| Transcriptional Activation | 2 | 2002 | 1748 | 0.040 |
Why?
|
| Transduction, Genetic | 1 | 2000 | 902 | 0.040 |
Why?
|
| Amino Acid Sequence | 3 | 2004 | 13425 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2009 | 4526 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 2004 | 17626 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2007 | 5800 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2009 | 17132 | 0.030 |
Why?
|
| Neoplasms | 1 | 2004 | 22389 | 0.030 |
Why?
|
| Kidney | 1 | 2008 | 7063 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2009 | 1684 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2000 | 2986 | 0.020 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 2009 | 158 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2009 | 450 | 0.020 |
Why?
|
| Time Factors | 1 | 2007 | 40267 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2009 | 1496 | 0.020 |
Why?
|
| Rec A Recombinases | 1 | 2003 | 50 | 0.010 |
Why?
|
| Nuclear Localization Signals | 1 | 2002 | 78 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 2 | 2000 | 6132 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 2000 | 5443 | 0.010 |
Why?
|
| Humans | 8 | 2009 | 768298 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2002 | 461 | 0.010 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2000 | 28 | 0.010 |
Why?
|
| Aotidae | 1 | 2000 | 57 | 0.010 |
Why?
|
| Animals | 5 | 2004 | 169322 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2009 | 4137 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2000 | 866 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2003 | 1526 | 0.010 |
Why?
|
| Herpesviridae Infections | 1 | 2000 | 269 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2000 | 1553 | 0.010 |
Why?
|
| Virus Activation | 1 | 2000 | 322 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 4168 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2000 | 577 | 0.010 |
Why?
|
| Tumor Virus Infections | 1 | 2000 | 438 | 0.010 |
Why?
|
| Mitochondrial Proteins | 1 | 2002 | 978 | 0.010 |
Why?
|
| Rabbits | 1 | 2000 | 4782 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2002 | 2887 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 4584 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2000 | 3957 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2000 | 1967 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2000 | 4120 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2000 | 4774 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2002 | 4940 | 0.010 |
Why?
|
| Base Sequence | 1 | 2000 | 12421 | 0.010 |
Why?
|
| Carcinoma | 1 | 2000 | 2340 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 2000 | 19019 | 0.000 |
Why?
|
| Gene Expression Regulation | 1 | 2002 | 11914 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 2000 | 13576 | 0.000 |
Why?
|